The global testing, inspection, and certification market is poised for remarkable expansion, aiming for an impressive ...

Yoshikazu Okubo killed the patient at the request of the victim in 2019, causing her death by acute drug poisoning.

ALS's fortunes have improved largely due to rising margins in life sciences and an increasing market share in geochemistry ...

Jarden analyst Jakob Cakarnis downgraded ALS Ltd. (CPBLF – Research Report) to a Hold today and set a price target of A$14.40. The company’s ...

Lee Wilson discovered she has a "100%" chance of developing ALS, after losing her father and grandmother to the disease Sara Belcher is a digital news writer/editor at PEOPLE. She has been working ...

Grammy winner John Driskell Hopkins, known as "Hop" from the Zac Brown Band, is turning his personal battle with amyotrophic lateral sclerosis, also known as ALS, into a mission to help others.

Whether you’re looking to take your career to the next level or jump into a new field, developing cloud skills and getting the right Amazon Web Services (AWS) certification can help open the door to ...

Trace Neu­ro­science, a start­up spun out of Maze Ther­a­peu­tics’ pipeline, broke cov­er Tues­day morn­ing with $101 mil­lion in fund­ing to de­vel­op treat­ments for amy­otroph ...

“Genomic-based therapies have begun to transform the lives of people living with ALS,” Gitler explained in a Nov. 12 release. “But so far, they have only been effective for those rare forms ...

Its therapy aims to restore a key protein, UNC13A,which is often low or absent in ALS patients and has been linked to the progression of the disease. Green previously cofounded Maze Therapeutics ...

Trace Neuroscience launched on Tuesday to announce that it is developing a genetic treatment targeting UNC13A, a gene linked to both a higher risk of ALS and faster disease progression.

Third Rock Ventures, the well-known backer of biotechnology companies, is leading a nine-figure fundraising round for a startup that aims to treat ALS by replacing broken genetic machinery. The ...